Gastric mucosal superoxide dismutases in Helicobacter pylori infection

Gut

Volumn 38, Issue 4, 1996, Pages 502-506

  Gotz J M ^a   Van Kan, C I ^a   Verspaget, H W ^a   Biemond, I ^a   Lamers, C B H W ^a   Veenendaal, R A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antioxidants; Gastric mucosa; Gastritis; Helicobacter pylori; Reactive oxygen species; Superoxide dismutase

Indexed keywords

SUPEROXIDE DISMUTASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BIOPSY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRITIS; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH MUCOSA;

EID: 0029925142     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.4.502     Document Type: Article

References (36)

1. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; i: 1273-5.
2. Taylor DN, Blaser MJ. The epidemiology of Helicobacter pylori infection. Epidemiol Rev 1991; 13: 42-59.
3. Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GNJ. Campylobacter pyloridis-associated chronic active antral gastritis: a prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988; 94: 33-40.
4. Sobala GM, Axon ATR, Dixon MF. Morphology of chronic antral gastritis: relationship to age, Helicobacter pylori status, and peptic ulceration. Eur J Gastroenterol Hepatol 1992; 4: 825-9.
5. Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989; 321: 1562-6.
6. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-9.
7. Correa P. Human gastric carcinogenesis: a multistep and multifactonal process. Cancer Res 1992; 52: 6735-40.
8. Parsonnet J, Hansen S, Rodriguez I, Gelb AB, Warnke RA, Jellum E, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330: 1267-71.
9. Hentschel E, Brandstätter G, Dragosics B, Hirschl AM, Nemec H, Schütze K, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308-12.
10. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-76.
11. Halliwell B, Gutteridge JMC, Cross CE. Free radicals, anti-oxidants, and human disease: where are we now? J Clin Lab Med 1992; 119: 598-620.
12. Davies GR, Simmonds NJ, Stevens TRJ, Sheaff MT, Banatvala N, Laurenson IF, et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994; 35: 179-85.
13. Davies GR, Banatvala N, Collins CE, Sheaff MT, Abdi Y, Clements L, et al. Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scand J Gastroenterol 1994; 29: 419-24.
14. Cheeseman KH, Slater TF. An introduction to free radical biochemistry. Br Med J Bull 1993; 49: 481-93.
15. Davies GR, Rampton DS. Helicobacter pylori, free radicals and gastroduodenal disease. Eur J Gastroenterol Hepatol 1994; 6: 1-10.
16. Niida H, Okada M, Takeuchi K, Okabe S. A new model of duodenal ulcers induced in rats by diethyldithiocarbamate, a superoxide dismutase inhibitor. Scand J Gastroenterol 1989; 162 (suppl): 116-9.
17. Naito Y, Yoshikawa T, Ando T, Kishi A, Ueda S, Oyamada H, et al. Changes in superoxide dismutase activity in the gastric mucosa of peptic ulcer patients. J Clin Gastroenterol 1992; 14 (suppl 1): S131-4.
18. Smith SM, Kvietys PR. Gastric ulcers; role of oxygen radicals. Clin Care Med 1988; 16: 892-8.
19. Mooney C, Keenan J, Munster D, Wilson I, Allardyce R, Bagshaw P, et al. Neutrophil activation by Helicobacter pylori. Gut 1991; 32: 853-7.
20. Mai UEH, Perez-Perez GI, Wahl LM, Wahl SM, Blaser MJ, Smith PD. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest 1991; 87: 894-900.
21. Rautelin H, Blomberg B, Fredlund H, Järnerot G, Danielsson D. Incidence of Helicobacter pylori strains activating neutrophils in patients with peptic ulcer disease. Gut 1993; 34: 599-603.
22. Ogino K, Oka S, Okazaki Y, Takemoto T. Gastric mucosal protection and superoxide dismutase. J Clin Gastroenterol 1988; 10 (suppl 1): S129-32.
23. Verspaget HW, van Ierssel AJHM, van Duijn W, MieremetOoms MAC, van Hogezand RA, Griffioen G, et al. Dysfunctional superoxide dismutases in inflamed intestine of patients with inflammatory bowel disease. Gastroenterology 1994; 106 (suppl): A790.
24. Veenendaal RA, Lichtendahl-Bernards AT, Peña AS, Endtz HPh, van Boven CPA, Lamers CBHW. Effect of transport medium and transportation time on culture of Helicobacter pylori from gastric biopsy specimens. J Clin Pathol 1993; 46: 561-3.
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-75.
26. Verspaget HW, Peña AS, Weterman IT, Lamers CBHW. Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content. Gut 1988; 29: 223-8.
27. Spiegelhalder C, Gerstenecker B, Kersten A, Schlitz E, Kist M. Purification of Helicobacter pylori superoxide dismutase and cloning and sequencing of the gene. Inject Immun 1993; 61: 5315-25.
28. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244: 6049-55.
29. Warner BB, Burhans MS, Clark JC, Wispe JR. Tumor necrosis factor-α increases Mn-SOD expression: protection against oxidant injury. Am J Physiol 1991; 260: L296-301.
30. Visner GA, Dougall WC, Wilson JM, Burr IA, Nick HS. Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. J Biol Chem 1990; 265: 2856-64.
31. Harris CA, Derbin KS, Hunte-McDonough B, Krauss MR, Chen KT, Smith DM, et al. Manganese superoxide dismutase is induced by IFN-γ in multiple cell types. J Immunol 1991; 147: 149-54.
32. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JL Mucosal tumour necrosis factor a and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991; 32: 1473-7.
33. Crabtree JE, Peichl P, Wyatt JI, Stachl U, Lindley IJD. Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection. Scan J Immunol 1993; 37: 65-7.
34. Mulder TPJ, Verspaget HW, Janssens AR, de Bruin PAF, Lamers CBHW. Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease. Gut 1991; 32: 1146-50.
35. Salo DC, Pacifici RE, Lin SW, Giulivi C, Davies KJA. Superoxide dismutase undergoes proteolysis and fragmentation following oxidative modification and inactivation. J Biol Chem 1990; 265: 11919-27.
36. Graham DY. Polymorphonuclear leucocytes traffic into the gastric mucosa and through the gastric mucosal barrier in H pylori infection: is that bad? In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori: Basic mechanisms to clinical cure. Dordrecht: Kluwer Academic, 1994: 214-21.